trofosfamide
- CAS No.
- 22089-22-1
- Chemical Name:
- trofosfamide
- Synonyms
- A-4828;Ccris 4442;Brn 0532530;Asta Z 4828;trofosfamide;TROPHOSPHAMIDE;Trofosfamide,Bacterial,Inhibitor,inhibit;2H-1,3,2-Oxazaphosphorin-2-amine, N,N,3-tris(2-chloroethyl)tetrahydro-, 2-oxide (9ci);3-(2-Chloroethyl)-2-(bis(2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine 2-oxide;3-(2-Chloroethyl)-2-(bis(2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorin 2-oxide
- CBNumber:
- CB3877124
- Molecular Formula:
- C9H18Cl3N2O2P
- Molecular Weight:
- 323.58
- MDL Number:
- MOL File:
- 22089-22-1.mol
| Melting point | 47-49°C |
|---|---|
| alpha | D25 -28.6° (c = 2 in CH3OH) |
| Boiling point | 104°C |
| Density | 1.35±0.1 g/cm3(Predicted) |
| storage temp. | -20°C Freezer |
| solubility | DMF: 50mg/mL; DMSO: 30mg/mL; Ethanol: 50mg/mL; PBS (pH 7.2): 10mg/mL |
| form | A crystalline solid |
| pka | -0.46±0.20(Predicted) |
| EWG's Food Scores | 1 |
| FDA UNII | H64JRU6GJ0 |
| NCI Drug Dictionary | trofosfamide |
| ATC code | L01AA07 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS08,GHS06 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H372-H301-H413-H340-H360-H350 | |||||||||
| Precautionary statements | P260-P264-P270-P314-P501-P264-P270-P301+P310-P321-P330-P405-P501 | |||||||||
| Toxicity | LD50 i.p. in mice: 212 mg/kg (Brock, Potel) | |||||||||
| NFPA 704 |
|
trofosfamide price More Price(10)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 21874 | Trofosfamide | 22089-22-1 | 5mg | $32 | 2024-03-01 | Buy |
| Cayman Chemical | 21874 | Trofosfamide | 22089-22-1 | 10mg | $50 | 2024-03-01 | Buy |
| Cayman Chemical | 21874 | Trofosfamide | 22089-22-1 | 25mg | $109 | 2024-03-01 | Buy |
| Cayman Chemical | 21874 | Trofosfamide | 22089-22-1 | 50mg | $169 | 2024-03-01 | Buy |
| ChemScene | CS-0078076 | Trofosfamide >98.0% | 22089-22-1 | 50mg | $200 | 2021-12-16 | Buy |
trofosfamide Chemical Properties,Uses,Production
Chemical Properties
Off-White Low Melting Solid
Originator
Ixoten,Asta,W. Germany,1973
Uses
Antineoplastic; one derivative
Definition
ChEBI: Trofosfamide is a member of ifosfamides.
Manufacturing Process
259 g (1 mol) of N,N-bis-(2-chloroethyl)-phosphoric acid amide dichloride,
209 g (1.2 mols) of N-(2-chloroethyl)-N-(3-hydroxypropyl)-amine
hydrochloride (crude), 1,000 cc of ethylene dichloride and 344 g (3.4 mols) of
triethylamine are the reactants. N,N-bis-(2-chloroethyl)-phosphoric acid amide
dichloride is dissolved in the methylene dichloride. N-(2-chloroethyl)-N-(3-
hydroxypropyl)-amine hydrochloride is suspended in this solution and
triethylamine is added thereto dropwise with stirring. The temperature of the
solution rises to boiling, After the termination of the addition, the mixture is
heated to boiling for another 6 hours. Thereafter, the reaction mixture is
cooled down and allowed to stand overnight at about 0°C. The precipitated
triethylamine hydrochloride is filtered off with suction. The resulting solution is
evaporated, the residue (about 370 g) is triturated with about 3.2 liters of
ether and is heated to boiling for a short period of time.
The ethereal solution is decanted from the insolubles (about 90 g). The
solution is rendered to pH 6.5 to 7 by the addition of ethereal hydrochloric
acid and then is filtered over charcoal and thereafter is evaporated. During
evaporation, the temperature should not rise above 40°C. The residue is
dissolved in ether and in an amount corresponding to half of its weight (240 g
of residue, dissolved in 120 cc of ether), the ethereal solution is cooled to -
5°C and is inoculated. After standing for 25 hours, 140 g have been separated
by crystallization. After separation by filtration with suction, the mother liquor
is diluted with ether to 5 times its volume, the solution is filtered over
charcoal, is again evaporated and the residue is again dissolved in a volume
corresponding to half of the weight of the residue. Another cooling to -5°C
and inoculation produces further 18 g of the desired compound. MP: 50° to
51°C. Total yield: 161 g (50% of the theoretical)
Therapeutic Function
Cancer chemotherapy
Safety Profile
Poison by intraperitoneal, subcutaneous, and intravenous routes. Moderately toxic by ingestion. Human mutation data reported. Human systemic effects by unspecified routes: hematuria, leukopenia, and thrombocytopenia. When heated to decomposition it emits very toxic fumes of Cl-, NOx, and POx.
trofosfamide Preparation Products And Raw materials
trofosfamide Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 19892 | 58 |
| Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | sales@molcore.com | China | 49739 | 58 |
| Aladdin Scientific | +1-833-552-7181 | sales@aladdinsci.com | United States | 52927 | 58 |
| J & K SCIENTIFIC LTD. | 010-82848833 400-666-7788 | jkinfo@jkchemical.com | China | 96815 | 76 |
| LGM Pharma | 1-(800)-881-8210 | inquiries@lgmpharma.com | United States | 2127 | 70 |
| Chemsky（shanghai）International Co.,Ltd. | 021-50135380 | shchemsky@sina.com | China | 32344 | 50 |
| Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | info@efebio.com | China | 9709 | 58 |
| Beijing Jin Ming Biotechnology Co., Ltd. | 010-60605840 18892239720 | psaitong@jm-bio.com | China | 12308 | 58 |
| Shenzhen Polymeri Biochemical Technology Co., Ltd. | +86-400-002-6226 13028896684 | sales@rrkchem.com | China | 55672 | 58 |
| Fan De(Beijing) Biotechnology Co., Ltd. | 15911056312 | liming@bio-fount.com | China | 9730 | 58 |